| 期刊論文| 1. | 李建良(20111015)。人身自由的憲法保障與強制隔離的違憲審查--釋字第690號解釋。臺灣法學雜誌，186，60-79。 延伸查詢 | | 2. | Deming, Meagan E.、Michael, Nelson L.、Robb, Merlin、Cohen, Myron S.、Neuzil, Kathleen M.(2020)。Accelerating Development of SARS-CoV-2 Vaccines: The Role for Controlled Human Infection Models。The New England Journal of Medicine，383(10)。  | | 3. | 陳仲嶙(20200600)。從防疫出國禁令爭議再訪法律保留的疆界。法律與生命科學，9(1)，1-37。 延伸查詢 | | 4. | 李建良(2020)。在瘟疫中思索自由。人文與社會科學簡訊，22(1)，30-33。 延伸查詢 | | 5. | Singh, Jerome Amir、Kochhar, Sonali、Wolff, Jonathan、The WHO ACT-Accelerator Ethics & Governance Working Group(2021)。Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group。Nature Medicine，27(4)，569-570。 | | 6. | 林明昕(20210114)。再論嚴重特殊傳染性肺炎防治及紓困振興特別條例第7條之合憲性爭議。臺灣法學雜誌，407，53-67。 延伸查詢 | | 7. | 吳全峰、劉靜怡、劉定基、翁逸泓、邱文聰(20210500)。科技防疫與個人資料保護。月旦裁判時報，107，88-104。 延伸查詢 | | 8. | 施明遠(20210500)。從公共衛生危機到國家安全意識--美國醫療對應措施立法之演進與分析。月旦法學，312，46-69。 延伸查詢 | | 9. | 林欣柔(20200600)。新冠肺炎流行下的公衛權力與界限。法律與生命科學，9(1)，67-89。 延伸查詢 | | 10. | 徐千惠、吳馥羽、吳彥慧(2020)。人體攻毒試驗應用於疫苗研發：過去、今日與未來。當代醫藥法規月刊，120，1-17。 延伸查詢 | | 11. | 許育典(20210700)。不同於憲法緊急狀態的法治國防疫措施--以法治國的國家保護義務為核心。月旦法學，314，182-190。 延伸查詢 | | 12. | 詹祐維(20200600)。傳染病防治法強制隔離措施之檢討--以釋字690號解釋為中心。萬國法律，231，13-23。 延伸查詢 | | 13. | 雷文玫(20210500)。防疫共同體的物資整備--從我國口罩光榮動員經驗看下一波超前部署所需要的法制整備。月旦法學，312，23-45。 延伸查詢 | | 14. | 劉宏恩(2020)。評我國食藥署關於COVID-9疫苗臨床試驗受試者徵求及緊急授權使用（EUA）之政策。生物醫學，13(4)，237-239。 延伸查詢 | | 15. | Adashi, E. Y.、Rajan, R. S.、Cohen, I. G.(2019)。When Science and Politics Collide: Enhancing the FDA。Science，364(6441)，628-631。 | | 16. | Anomaly, J.、Savulescu, J.(2019)。Compensation for Cures: Why We Should Pay a Premium for Participation in 'Challenge Studies'。Bioethics，33(7)，792-797。 | | 17. | Blum, J. D.、Paradise, J.(2018)。Public Health Preparedness & Response: An Exercise in Administrative Law。The DePaul Journal of Health Care Law，20(2)，(1)1-(1)21。 | | 18. | Borah, R.(2020)。Every Minute Matters: Improving the Regulatory Response to Vaccine Development During a Public Health Emergency。Food and Drug Law Journal，75(2)，311-345。 | | 19. | Coglianese, C.(20200420)。Obligation Alleviation During the COVID-19 Crisis。Regulatory Review。 | | 20. | Coglianese, C.、Scheffler, G.、Walters, D. E.(2021)。Unrules。Stanford Law Review，73(4)，885-967。 | | 21. | Eyal, N.(2020)。Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events。Ethics & Human Research，42(4)，24-34。 | | 22. | Eyal, N.、Lipsitch, M.、Smith, P. G.(2020)。Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure。The Journal of Infectious Diseases，221(11)，1752-1756。 | | 23. | Flore, E. F.、Frontera, W. R.、Andrasik, M. P.、Rio, C.、Mondriguez-Gonzâlez, A.、Price, S. A.、Krantz, E. M.、Pergam, S. A.、Silver, J. K.(2021)。Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials。JAMA Network Open，4(2)，(e2037640)1-(e2037640)11。 | | 24. | Friesen, P.、Caplan, A. L.、Miller, J. E.(2021)。COVID-19 Vaccine Research and the Trouble with Clinical Equipoise。Lancet，397(10274)。 | | 25. | Ganz, D. J.(2020)。Reconsidering Discretion in Expedited Vaccine Approval in Light of the Novel Coronavirus。University of Illinois Law Review Online，2020，203-220。 | | 26. | Wiley, L. F.、Bagenstos, S. R.(2020)。The Personal Responsibility Pandemic: Centering Solidarity in Public Health and Employment Law。Arizona State Law Journal，52(4)，1235-1302。 | | 27. | Witt, J. F.(20200330)。The Law of Salus Populi: Epidemics and the Law。Yale Review。 | | 28. | Yearby, R.、Mohapatra, S.(2020)。Law, Structural Racism, and the COVID-19 Pandemic。Journal of Law and the Biosciences，7(1)，(lsaa036)1-(lsaa036)20。 | | 29. | Sturgis, P.、Brunton-Smith, I.、Jackson, J.(2021)。Trust in Science, Social Consensus and Vaccine Confidence。Nature Human Behaviour，5，1528-1534。 | | 30. | Walsh, Daniel(2021)。COVID-19: A Crisis and an Opportunity to Improve the Emergency Use Authorization Process。Minnesota Journal of Law, Science & Technology，22(2)，169-220。 | | 31. | Whelan, A. M.(2021)。Unequal Representation: Women in Clinical Research。Cornell Law Review Online，106(3)，87-128。 | | 32. | WHO Ad Hoc Expert Group on the Next Steps for Covid-19 Vaccine Evaluation(2021)。Placebo-Controlled Trials of Covid-19 Vaccines: Why We Still Need Them。New England Journal of Medicine，384(2)，(e2)1-(e2)3。 | | 33. | Sherwin, B. D.(2021)。Anatomy of a Conspiracy Theory: Law, Politics, and Science Denialism in the Era of COVID-19。Texas A&M Law Review，8(3)，537-582。 | | 34. | Solbakk, Jan Helge、Bentzen, Heidi Beate、Holm, Søren、Heggestad, Anne Kari Tolo、Hofmann, Bjørn、Robertsen, Annette、Alnæs, Anne Hambro、Cox, Shereen、Pedersen, Reidar、Bernabe, Rose(2021)。Back to WHAT? The Role of Research Ethics in Pandemic Times。Medicine, Health Care and Philosophy，24(1)，3-20。 | | 35. | Steel, R.、Buchak, L.、Eyal, N.(2020)。Why Continuing Uncertainties Are No Reason to Postpone Challenge Trials for Coronavirus Vaccines。Journal of Medical Ethics，46(12)，808-812。 | | 36. | Steinzor, R.(20200914)。The pandemic's toll on science。Regulatory Review。 | | 37. | Plotkin, S. A.、Caplan, A.(2020)。Extraordinary Diseases Require Extraordinary Solutions。Vaccine，35(24)，3987-3988。 | | 38. | Reiss, D. R.(2020)。The COVID-19 Vaccine Dilemma。The Administrative Law Review Accord，6(1)，49-83。 | | 39. | Rizzi, M.(2020)。The Road to a Vaccine for COVID-19: Regulatory and Policy Infrastructure, Incentives and Obstacles。European Pharmaceutical Law Review，4(2)，98-103。 | | 40. | Shah, Anand、Marks, Peter W.、Hahn, Stephen M.(2020)。Unwavering Regulatory Safeguards for COVID-19 Vaccines。JAMA，324(10)，931-932。 | | 41. | Gouglas, D.、Le, T. T.、Henderson, K.、Kaloudis, A.、Danielsen, T.、Hammersland, N. C.、Robinson, J. M.、Heaton, P. M.、Rottingen, J.(2018)。Estimating the Cost of Vaccine Development Against Epidemic Infectious Diseases: a Cost Minimisation Study。The Lancet Global Health，6(12)，e1386-e1396。 | | 42. | Grady, C.(2004)。Ethics of Vaccine Research。Nature Immunology，5(5)，465-468。 | | 43. | Hermes, C.、Wethington, N.(2020)。Balancing Hope and Proof: Investigational Products During the COVID-19 Pandemic。Health Lawyer，33(2)，6-9。 | | 44. | Hodge, J. G.、Piatt, J. L.、Reinke, H. N.、Carey, E.(2021)。COVID's Constitutional Conundrum: Assessing Individual Rights in Public Health Emergencies。Tennessee Law Review，88(1)。 | | 45. | Hsu, N. S.、Hendriks, S.、Ramos, K. M.、Grady, C.(2021)。Ethical Considerations of COVID-19-Related Adjustments to Clinical Research。Nature Medicine，27(2)，191-193。 | | 46. | Johnson, E. E.、Bailey, T. C.(2020)。Legal Lessons from a Very Fast Problem: COVID-19。Stanford Law Review Online，73，89-103。 | | 47. | Karako-Eyal, N.(2019)。Beyond the Ethical Boundaries of Solidarity: Increasing Vaccination Rates Through Mandatory Education to Solidarity。Texas A&M Law Review，6(2)，345-390。 | | 48. | Krammer, F.(2020)。SARS-CoV-2 Vaccines in Development。Nature，586(7830)，516-527。 | | 49. | Largent, E. A.(2016)。EBOLA and FDA: Reviewing the Response to the 2014 Outbreak, to Find Lessons for the Future。Journal of Law and the Biosciences，3(3)，489-537。 | | 50. | Lin, Ching-Fu、Wu, Chien-Huei、Wu, Chuan-Feng(2020)。Reimagining the Administrative State in Times of Global Health Crisis: An Anatomy of Taiwan's Regulatory Actions in Response to the COVID-19 Pandemic。European Journal of Risk Regulation，11(S2)，256-272。 | | 51. | Lee, K.、Eyal, N.(20210513)。Do Controlled Human Infection Studies Put Bystanders at Higher Risk Than Conventional Field Trials?。Journal of Medical Ethics。 | | 52. | London, Alex John、Kimmelman, Jonathan(2020)。Against pandemic research exceptionalism。Science，368(6490)，476-477。 | | 53. | Nguyen, X.(2021)。Contract as Emergency Law。Washington International Law Journal，30(3)，420-469。 | | 54. | Paradise, J.、Bavlsik, B.(2021)。Pandemic Politics, Public Health, and the FDA。Belmont Law Review，8(2)，301-341。 | | 55. | Lynch, H. F.、Joffe, S.、McCoy, M. S.(2021)。The Limits of Acceptable Political Influence over the FDA。Nature Medicine，27(2)，188-190。 | | 56. | Lynch, H. F.、Dickert, N. W.、Zettler, P. J.、Joffe, S.、Largent, E. A.(2020)。Regulatory Flexibility for COVID-19 Research。Journal of Law and the Biosciences，7(1)，(lsaa057)1-(lsaa057)10。 | | 57. | Lurie, N.、Cramer, J. P.、Hatchett, R. J.(2021)。The Vaccine Revolution: How mRNA Can Stop the Next Pandemic Before It Starts。Foreign Affairs，100(3)，128-135。 | | 58. | 陳嘉新(20200600)。防疫共同體的生命政治。臺灣社會學刊，67，237+239-246。 延伸查詢 | | 59. | 吳秦雯(20200600)。從SARS到COVID-19：司法院釋字第690號解釋架構下之傳染病防治法制與基本權限制。法律與生命科學，9(1)，91-112。 延伸查詢 | 研究報告| 1. | Lynch, H. F.、Darton, T.、Largent, E. A.、Levy, J.、McCormick, F.、Ogbogu, U.、Payne, R.、Roth, A. E.、Shah, A. J.、Smiley, T.(2020)。Ethical Payment to Participants in Human Infection Challenge Studies, With a Focus on Sars-Cov-2: Report and Recommendations。 | 圖書| 1. | National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research(1978)。The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research。 | | 2. | Prainsack, Barbara、Buyx, Alena(2011)。Solidarity: Reflections on an Emerging Concept in Bioethics。Nuffield Council on Bioethics。 | | 3. | Gostin, Lawrence O.、Wiley, Lindsay F.、蘇玉菊、劉碧波、穆冠群、劉汗曦(2019)。公共衛生法：權力、責任、限制。元照。 延伸查詢 | | 4. | Allen, D.、Stanczyk, L.、Cohen, I. G.、Shachar, C.、Sethi, R.、Weyl, G.、Brooks, R.(2020)。Securing Justice, Health, and Democracy Against the Covid-19 Threat。Edmond J. Safra Center for Ethics。 | | 5. | Cammet, M.、Lieberman, E.(2020)。Building Solidarity: Challenges, Options, and Implications for Covid-19 Responses。 | | 6. | Council for International Organizations of Medical Sciences(2016)。International Ethical Guidelines for Health-Related Research Involving Humans。CIOMS。 | | 7. | Gostin, L. O.(2010)。Public Health Law and Ethics: A Reader。University of California Press。 | | 8. | National Academies of Sciences, Engineering, and Medicine(2017)。Integrating Clinical Research into Epidemic Response: the Ebola Experience。The National Academies Press。 | | 9. | Nuffield Council on Bioethics(2020)。Research in Global Health Emergencies: Ethical Issues。Nuffield Council on Bioethics。 | 其他| 1. | Chang, Wen-Chen(20200321)。Taiwan's Fight against COVID-19: Constitutionalism, Laws, and the Global Pandemic，https://verfassungsblog.de/taiwans-fight-against-covid-19-constitutionalism-laws-and-the-global-pandemic/。 | | 2. | Brown, Beatrice(20201030)。Ethics of Emergency Use Authorization During the Pandemic，https://www.thehastingscenter.org/ethics-of-emergency-use-authorization-during-the-pandemic/。 | | 3. | Chernoguz, J.(20200325)。Protecting Rights in a Global Crisis，https://today.law.harvard.edu/protecting-rights-in-a-global-crisis/。 | | 4. | Ginsburg, T.，Versteeg, M.(2020)。States of Emergencies: Part I，https://harvardlawreview.org/blog/2020/04/states-of-emergencies-part-i/。 | | 5. | Miller, F. G.(20201027)。Ethics of Placebo Controls in Coronavirus Vaccine Trials，https://www.thehastingscenter.org/ethics-of-placebo-controls-in-coronavirus-vaccine-trials/。 | | 6. | Macklin, R.(20200615)。Human Challenge Studies for Covid-19 Vaccine: Questions About Benefits and Risks，https://www.thehastingscenter.org/human-challenge-studies-for-covid-19-vaccine-questions-about-benefits-and-risks/。 | 圖書論文| 1. | Bayer, R.、Fairchild, A. L.(2010)。The Genesis of Public Health Ethics。Public Health Law and Ethics: A Reader。University of California Press。 | | 2. | Callahan, D.、Jennings, B.(2010)。Ethics and Public Health: Forging a Strong Relationship。Public Health Law and Ethics: A Reader。University of California Press。 | | 3. | Jennings, B.、Arras, J. D.(2016)。Ethical Aspects of Public Health Emergency Preparedness and Response。Emergency Ethics: Public Health Preparedness and Response。Oxford University Press。 | |